Results 31 to 40 of about 213,434 (307)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. [PDF]

open access: yes, 2018
BackgroundThe value of induction chemotherapy (ICT) remains under investigation despite decades of research. New advancements in the field, specifically regarding the induction regimen of choice, have reignited interest in this approach for patients with
Cohen, EEW   +6 more
core   +1 more source

Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study

open access: yesTumor Biology, 2019
MicroRNAs are a class of small, endogenous, noncoding 18- to 24-nucleotide-long RNAs that can regulate multiple processes related to cancer progression.
Hikaru Nakashima   +13 more
doaj   +1 more source

Epidemiology and incidence of oral squamous cell carcinoma in the Iraqi population over 5 years (2014–2018)

open access: yesHealth Science Reports, 2023
Background Oral squamous cell carcinoma is one of the most common and life‐threatening neoplasms worldwide, and is responsible for approximately 90% of all oral malignancies. Aim This study was aimed at providing updated information on oral squamous cell
Muhanad L. Alshami   +3 more
doaj   +1 more source

HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis [PDF]

open access: yes, 2009
Penile verrucous carcinoma is a rare disease and little is known of its aetiology or pathogenesis. In this study we examined cell-cycle proteins expression and correlation with human papillomavirus infection in a series of 15 pure penile verrucous ...
A Ouban   +58 more
core   +1 more source

Chewstick trauma-induced oral squamous cell carcinoma

open access: yesIndian Journal of Dental Sciences, 2018
Oral carcinoma is one of the most prevalent cancers and one of the 10th most common causes of death worldwide. Oral squamous cell carcinoma accounts for nearly 90% of all oral carcinomas.
Ashutosh Nirola, Ranchana Garg
doaj   +1 more source

Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma

open access: yesHead & Face Medicine, 2021
Background Oral cavity cancer ranks the sixth most common malignancy worldwide, of which oral squamous cell carcinoma is the predominant type. This study aimed to investigate the function and the underlying mechanism of resistin like beta (RETNLB) in ...
Hong Jin   +3 more
doaj   +1 more source

Prognoses of Oral Basaloid Squamous Cell Carcinoma and Squamous Cell Carcinoma [PDF]

open access: yesArchives of Otolaryngology–Head & Neck Surgery, 2004
To compare clinical and prognostic features in patients with basaloid squamous cell carcinoma (BSCC), poorly differentiated squamous cell carcinoma (PDSCC), and well to moderately differentiated squamous cell carcinoma (W/MSCC) of the oral cavity.Retrospective cohort.Referral tertiary center.Seventeen patients with primary oral BSCC, 27 with PDSCC, and
Fernanda C Grizzo, de Sampaio Góes   +5 more
openaire   +2 more sources

Prognostic significance of serine-phosphorylated STAT3 expression in pT1-T2 oral tongue carcinoma [PDF]

open access: yes, 2015
Objectives. Phosphorylated (activated) STAT3 (pSTAT3) is a regulator of numerous genes that play an essential part in the onset, development and progression of cancer; it is involved in cell proliferation and preventing apoptosis, and in invasion ...
Cappellesso, R   +10 more
core   +3 more sources

miRNA-199b-5p suppresses of oral squamous cell carcinoma by targeting apical-basolateral polarity via Scribble/Lgl

open access: yesMolecular Therapy: Nucleic Acids
In epithelial cells, Scribble forms cell-cell junctions and contributes to cell morphology and homeostasis by regulating apical-basolateral polarity in mammals and functions as a tumor suppressor in many carcinomas. The initial diagnosis of oral squamous
Shihyun Kim   +4 more
doaj   +1 more source

Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma

open access: yesTumor Biology, 2017
YM155, a small molecule inhibitor of survivin, has been studied in many tumors. It has been shown that YM155 inhibited oral squamous cell carcinoma through promoting apoptosis and autophagy and inhibiting proliferation.
Kong-Liang Li   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy